Murakami, Koji <br/><br/>
Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.  [electronic resource] 

 -  Brain research  Aug 2013 
 - 84-93 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-6240 
<br/><br/><label>Standard No.: </label>10.1016/j.brainres.2013.06.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amides--administration & dosage<br/>Animals<br/>Benzofurans--administration & dosage<br/>Cannabinoid Receptor Agonists--administration & dosage<br/>Disease Models, Animal<br/>Fibrinolytic Agents--administration & dosage<br/>Infarction, Middle Cerebral Artery--drug therapy<br/>Male<br/>Neuroprotective Agents--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Tissue Plasminogen Activator--administration & dosage